Skip to main content
SpringerLink
Log in

Muskelrelaxantien

  • Chapter
Arzneiverordnungs-Report 2006

  • 418 Accesses

Auszug

Nach einem Verordnungsrückgang im Jahr 2004 wurden die meisten Muskelrelaxantien 2005 wieder häufiger verordnet. Das peripher muskelrelaxierend wirkende Botulinumtoxin hält auch 2005 vor Tetrazepam seine Spitzenposition als der nach Tagesdosen am häufigsten verordnete Wirkstoff.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 44.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Bröse HD, Repges R, Dethlefsen U (1996): Therapie schmerzhafter Kontraktionen der Skelettmuskulatur — Doppelblinder Parallelgruppenvergleich zwischen den zentral wirksamen Myotonolytika Methocarbamol und Tetrazepam. Münch Med Wschr 138: 726–731.

    Google Scholar 

  • Deutsche Gesellschaft für Neurologie (2002): Leitlinie Spastik. http://www.dgn.org/130.0.html.

    Google Scholar 

  • Costa J, Espírito-Santo C, Borges A, Ferreira JJ, Coelho M, Moore P, Sampaio C (2004): Botulinum toxin type A therapy for blepharospasm. In: The Cochrane Database of Systematic Reviews: Reviews 2004, Issue 2, John Wiley & Sons, Ltd Chichester, UK.

    Google Scholar 

  • Costa J, Espírito-Santo C, Borges A, Ferreira JJ, Coelho M, Moore P, Sampaio C (2005a): Botulinum toxin type A therapy for cervical dystonia. In: The Cochrane Database of Systematic Reviews: Reviews 2005, Issue 1, John Wiley & Sons, Ltd Chichester, UK.

    Google Scholar 

  • Costa J, Espírito-Santo C, Borges A, Ferreira JJ, Coelho M, Moore P, Sampaio C. Botulinum toxin type A therapy for hemifacial spasm. (2005b): The Cochrane Database of Systematic Reviews: Reviews 2005, Issue 1, John Wiley & Sons, Ltd Chichester, UK.

    Google Scholar 

  • Gready DM (1976): Parafon forte® versus Robaxisal® in skeletal muscle disorders: a double-blind study. Curr Therap Res 20: 666–673.

    CAS  Google Scholar 

  • Keane RE, Simiand J, Morre M, Biziere K (1988a): Tetrazepam: a benzodiazepine which dissociates sedation from other benzodiazepine activities. I. Psychopharmacological profile in rodents. J Pharmacol Exp Ther 245: 692–698.

    PubMed  CAS  Google Scholar 

  • Keane RE, Bachy A, Morre M, Biziere K (1988b): Tetrazepam: a benzodiazepine which dissociates sedation from other benzodiazepine activities. II. In vitro and in vivo interactions with benzodiazepine binding sites. J Pharmacol Exp Ther 245: 699–705.

    PubMed  CAS  Google Scholar 

  • Kirschner J, Berweck S, Mall V, Korinthenberg R, Heinen F (2001): Botulinumtoxin — Neue Therapieoption für Kinder mit Zerebralparese. Dtsch Ärzteblatt 98: A3375–A3379.

    Google Scholar 

  • Middleton RSW (1984): A comparison of two analgesic muscle relaxant combinations in acute back pain. Br J Clin Pract 38: 107–109.

    PubMed  CAS  Google Scholar 

  • Preston KL, Guarino JJ, Kirk WT, Griffiths RR (1989): Evaluation of the abuse potential of methocarbamol. J Pharmacol Exp Ther 248: 1146–1157.

    PubMed  CAS  Google Scholar 

  • Preston KL, Wolf B, Guarino JJ, Griffiths RR (1992): Subjective and behavioral effects of diphenhydramine, lorazepam and methocarbamol: evaluation of abuse liability. J Pharmacol Exp Ther 262: 707–720.

    PubMed  CAS  Google Scholar 

  • Shakespeare DT, Boggild M, Young C (2003): Anti-spasticity agents for multiple sclerosis (Cochrane Review). In: The Cochrane Library, Issue 1, 2003. Oxford: Update Software.

    Google Scholar 

  • Simiand J, Keane PE, Biziere K, Soubrie P (1989): Comparative study in mice of tetrazepam and other centrally active skeletal muscle relaxants. Arch Int Pharmacodyn Ther 297: 272–285.

    PubMed  CAS  Google Scholar 

  • Tisdale SA, Ervin DK (1975): A controlled study of methocarbamol (Robaxin®) in acute painful musculoskeletal conditions. Curr Ther Res 17: 525–530.

    PubMed  Google Scholar 

  • Valtonen EJ (1975): A double-blind trial of methocarbamol versus placebo in painful muscle spasm. Curr Med Res Op 3: 382–385.

    CAS  Google Scholar 

  • Waelbroeck M, Camus J, Tastenoy M, Lambrecht G, Mutschler E, Kropfgans M et al (1993): Thermodynamics of antagonist binding to rat muscarinic M2 receptors: antimuscarinics of the pridinol, sila-pridinol, diphenidol and sila-diphenidol type. Br J Pharmacol 109: 360–370.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Ludwigstr. 37, 79104, Freiburg

    Dr. rer. nat. Judith Günther

Authors
  1. Dr. rer. nat. Judith Günther
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Pharmakologisches Institut, Universität Heidelberg, Im Neuenheimer Feld 366, 69120, Heidelberg

    Ulrich Schwabe

  2. Bachstraße 29, 50858, Köln

    Dieter Paffrath

Rights and permissions

Reprints and permissions

Copyright information

© 2007 Springer Medizin Verlag Heidelberg

About this chapter

Cite this chapter

Günther, J. (2007). Muskelrelaxantien. In: Schwabe, U., Paffrath, D. (eds) Arzneiverordnungs-Report 2006. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-34370-7_39

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-34370-7_39

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-34369-1

  • Online ISBN: 978-3-540-34370-7

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation